Epitranscriptomic regulation by m6A in immunity and autoimmune disorders: emerging mechanisms and clinical perspectives - Top-Institutions - MDSpire

Epitranscriptomic regulation by m6A in immunity and autoimmune disorders: emerging mechanisms and clinical perspectives

  • By

  • Madiha Maqsood

  • Chunai Zhan

  • Muhammad Hassan

  • Xinyu Li

  • Long Mei

  • Boyang Yang

  • Wenwen Zhu

  • Wei Shao

  • July 3, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    The University of Chicago
    The University of Chicago

    Chicago, Illinois

    Key Differentiators

    • Immunology

  • #2

    Yale University
    Yale University

    New Haven, Connecticut

    Key Differentiators

    • Immunology

Original Source(s)

Epitranscriptomic regulation by m6A in immunity and autoimmune disorders: emerging mechanisms and clinical perspectives

  • by Madiha Maqsood, Chunai Zhan, Muhammad Hassan, Xinyu Li, Long Mei, Boyang Yang, Wenwen Zhu, Wei Shao

  • July 3, 2026

Related Content

Predicting anti-CCP positivity and early rheumatoid arthritis onset from routine laboratory parameters: a SHAP-explained machine learning pipeline

Development and validation of a multimodal interpretable machine learning model for the identification of osteoporosis in patients with type 2 diabetes mellitus: a multicenter retrospective study

FDA Approves Pediatric Risankizumab

Approval expands risankizumab use to pediatric plaque psoriasis and psoriatic arthritis and includes a new 55-mg prefilled syringe for weight-based dosing in patients weighing less than 40 kg.